|
LV15362A
|
|
Method for producing (1s)- and (1r)-enantiomer of 1-(tricyclo[3.3.1.1~3,7~]dec-1-yl)ethanamine hydrochloride
|
|
LV15197A
|
|
Hepatoprotective preparation of plant origin
|
|
LV15152A
|
|
Method for producing furaginum
|
|
LV15129A
|
|
Pharmaceutical composition for the prevention and treatment of inflammatory conditions
|
|
LV15081A
|
|
Polymorphs of furazidine
|
|
LV15072A
|
|
Pharmaceutical composition for the prevention and treatment of diseases associated with elevated inos gene
|
|
LV15016A
|
|
Polymorphyc forms of n-carbamoyl-4(r)-phenyl-2-pyrrolidinone
|
|
LV15015A
|
|
Salt of 3-carboxy-4-(r)-phenylpyrrolidinone-2 and uses thereof
|
|
LV14983A
|
|
Method for producing intermediates of phenibut
|
|
LV13630B
|
|
Method of preparation and use of pharmaceutically active n-carbamoylmethyl-4(r)-phenyl-2-pyrrolidinone
|
|
LV13631B
|
|
Manufacturing method of n-carbamoylmethyl-4(r)-phenyl-2-pyrrolidinone
|
|
LV13635B
|
|
Enzymatic resolution of racemic 3-aryl-4-aminobutyric acids
|
